Vitexin-4 ″-O-glucoside alleviates acetaminophen-induced acute liver injury.
10.3724/zdxbyxb-2024-0381
- Author:
Fan DONG
1
;
Shanglei LAI
2
;
Jiannan QIU
3
;
Xiaobing DOU
4
,
5
Author Information
1. School of Public Health, Zhejiang Chinese Medical University, Hangzhou 310053, China. 173195226@qq.com.
2. Medical Research Center, Shaoxing People's Hospital, Shaoxing 312000, Zhejiang Province, China.
3. School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
4. School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. xbdou77@
5. com.
- Publication Type:Journal Article
- Keywords:
Acetaminophen;
Acute liver injury;
Endoplasmic reticulum stress;
Inflammation;
Mice;
Mitogen-activated protein kinase signaling pathway;
Oxidative stress;
Vitexin-4 ″- O-glucoside
- MeSH:
Animals;
Endoplasmic Reticulum Chaperone BiP;
Mice;
Acetaminophen/adverse effects*;
Mice, Inbred C57BL;
Chemical and Drug Induced Liver Injury/prevention & control*;
Glucosides/therapeutic use*;
Oxidative Stress/drug effects*;
Male;
Apigenin/therapeutic use*;
Liver/drug effects*;
Tumor Necrosis Factor-alpha/metabolism*;
Endoplasmic Reticulum Stress/drug effects*;
X-Box Binding Protein 1;
Endoribonucleases/metabolism*;
Interleukin-1beta/metabolism*;
Interleukin-6/metabolism*;
Protein Serine-Threonine Kinases
- From:
Journal of Zhejiang University. Medical sciences
2025;54(3):307-317
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To explore the protective effect of vitexin-4 ″-O-glucoside (VOG) against acetaminophen-induced acute liver injury in mice and its underlying mechanism.
METHODS:C57BL/6 mice were randomly divided into 4 groups: normal control group, model control group, low-dose group of VOG (30 mg/kg), and high-dose group of VOG (60 mg/kg). Acute liver injury was induced by intraperitoneal injection of acetaminophen (500 mg/kg). VOG was administrated by gavage 2 h before acetaminophen treatment in VOG groups. The protective effect of VOG against acute liver injury was evaluated by detecting alanine transaminase (ALT), aspartate transaminase (AST) levels and hematoxylin and eosin staining. The malondialdehyde (MDA) content, superoxide dismutase (SOD) and catalase (CAT) activity in liver were detected to evaluate the hepatic oxidative stress. The expression levels of tumor necrosis factor (TNF)-α, Il-1β, and Il-6 in liver were detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The expression levels of phosphorylated c-jun N-terminal kinase (JNK)/JNK, phosphorylated p38/p38, inositol-requiring enzyme 1 alpha (IRE-1α), X-box binding protein 1s (XBP1s), and glucose-regulated protein 78 (GRP78) in liver were detected by Western blotting. An endoplasmic reticulum stress model was established in AML-12 cells using tunicamycin. Cell viability was assessed using the CCK-8 assay, and the degree of cell damage was detected by lactate dehydrogenase (LDH) assay. The gene expression levels of Ire-1α, Xbp1s, and Grp78 in the cells were detected using qRT-PCR.
RESULTS:In the animal experiments, compared with the model control group, VOG significantly improved plasma ALT and AST levels, liver MDA content, as well as SOD and CAT activities. VOG also reduced the expression levels of Tnf-α, Il-1β, and Il-6 in the liver, and improved protein phosphorylation levels of JNK and p38, as well as the protein expression levels of IRE-1α, XBP1s, and GRP78. In cell experiments, VOG pretreatment enhanced cell viability, reduced LDH release and decreased the mRNA expression of Ire-1α, Xbp1s, and Grp78.
CONCLUSIONS:VOG can suppress inflammation and oxidative stress, and alleviate acetaminophen-induced acute liver injury in mice by suppressing endoplasmic reticulum stress and modulating the MAPK signaling pathway.
